Use of Benzodiazepines in Panic Disorder
Overview
Authors
Affiliations
Over the past 15 years, benzodiazepines have been used successfully to treat panic disorder with agoraphobia, but not without some controversy. Efficacy and side effect data from the principal benzodiazepine outcome studies of panic disorder demonstrate that alprazolam, lorazepam, and clonazepam are all clinically effective. Clonazepam has several advantages over other benzodiazepines and can be considered a first-line agent for panic disorder. Benzodiazepines in general are therapeutically effective for a broad range of panic disorder symptoms. Their effect is rapid and maintained without dose increase over a 7- to 8-month period. Discontinuation-related difficulties can occur in a considerable number of patients, but these can be decreased in several ways.
Roy M, Sarkar B, Kundu S Heliyon. 2024; 10(13):e33929.
PMID: 39071685 PMC: 11283148. DOI: 10.1016/j.heliyon.2024.e33929.
Treatment of noncardiac chest pain of psychological origin.
Olden K Curr Treat Options Gastroenterol. 2006; 9(1):51-8.
PMID: 16423313 DOI: 10.1007/s11938-006-0023-6.
Three year naturalistic outcome study of panic disorder patients treated with paroxetine.
Dannon P, Iancu I, Cohen A, Lowengrub K, Grunhaus L, Kotler M BMC Psychiatry. 2004; 4:16.
PMID: 15191617 PMC: 441384. DOI: 10.1186/1471-244X-4-16.
A risk-benefit assessment of pharmacological treatments for panic disorder.
Bennett J, Moioffer M, Stanton S, Dwight M, Keck Jr P Drug Saf. 1998; 18(6):419-30.
PMID: 9638387 DOI: 10.2165/00002018-199818060-00003.
Broderick P, Hope O, Jeannot P Prog Neuropsychopharmacol Biol Psychiatry. 1998; 22(2):353-86.
PMID: 9608607 PMC: 7131360. DOI: 10.1016/s0278-5846(98)00010-4.